These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16496247)
1. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia, and Hungary. Konstas AG; Hollo G; Astakhov YS; Teus MA; Akopov EL; Jenkins JN; Stewart WC Eur J Ophthalmol; 2006; 16(1):60-6. PubMed ID: 16496247 [TBL] [Abstract][Full Text] [Related]
2. Factors associated with long-term progression or stability in exfoliation glaucoma. Konstas AG; Hollo G; Astakhov YS; Teus MA; Akopov EL; Jenkins JN; Stewart WC Arch Ophthalmol; 2004 Jan; 122(1):29-33. PubMed ID: 14718291 [TBL] [Abstract][Full Text] [Related]
3. Is there any difference in target intraocular pressure for exfoliative glaucoma patients with cardiovascular disease history? Holló G; Cvenkel B; Teus MA; Irkec MT; Astakhov YS; Chiselita D; Petkova N; Liehneová I; Kaluzny BJ; Kóthy P; Bozkurt B; Akopov EL; Stewart JA; Kristoffersen MS; Kristoffersen CJ; Stewart WC Eur J Ophthalmol; 2010; 20(6):1000-6. PubMed ID: 20544681 [TBL] [Abstract][Full Text] [Related]
4. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma. Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322 [TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndrome. Levkovitch-Verbin H; Habot-Wilner Z; Burla N; Melamed S; Goldenfeld M; Bar-Sela SM; Sachs D Ophthalmology; 2008 Jan; 115(1):104-8. PubMed ID: 17561259 [TBL] [Abstract][Full Text] [Related]
6. Natural history of intraocular pressure in the early manifest glaucoma trial: A 6-year follow-up. Hyman L; Heijl A; Leske MC; Bengtsson B; Yang Z; Arch Ophthalmol; 2010 May; 128(5):601-7. PubMed ID: 20457982 [TBL] [Abstract][Full Text] [Related]
7. Comparison of primary open-angle glaucoma and exfoliation glaucoma at diagnosis. Tarkkanen AH; Kivelä TT Eur J Ophthalmol; 2015; 25(2):137-9. PubMed ID: 25198170 [TBL] [Abstract][Full Text] [Related]
8. Reproducibility of the water-drinking test in patients with exfoliation syndrome and exfoliative glaucoma. Özyol E; Özyol P; Karalezli A Acta Ophthalmol; 2016 Dec; 94(8):e795-e798. PubMed ID: 27316559 [TBL] [Abstract][Full Text] [Related]
9. Long-term progression at individual mean intraocular pressure levels in primary open-angle and exfoliative glaucoma. Stewart WC; Kolker AE; Sharpe ED; Day DG; Konstas AG; Hollo G; Astakhov YS; Teus MA; Stewart JA Eur J Ophthalmol; 2008; 18(5):765-70. PubMed ID: 18850556 [TBL] [Abstract][Full Text] [Related]
10. Relationship between intraocular pressure and rate of visual field progression in treated glaucoma. Rao HL; Addepalli UK; Jonnadula GB; Kumbar T; Senthil S; Garudadri CS J Glaucoma; 2013 Dec; 22(9):719-24. PubMed ID: 22595936 [TBL] [Abstract][Full Text] [Related]
11. Combined cataract and trabeculectomy surgery in eyes with pseudoexfoliation glaucoma. Shingleton BJ; Wooler KB; Bourne CI; O'Donoghue MW J Cataract Refract Surg; 2011 Nov; 37(11):1961-70. PubMed ID: 21907537 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Topically Administered Rho-Kinase Inhibitor AR-12286 in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma. Skaat A; Jasien JV; Ritch R J Glaucoma; 2016 Sep; 25(9):e807-14. PubMed ID: 27552517 [TBL] [Abstract][Full Text] [Related]
14. Visual acuity and intraocular pressure after Descemet's stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Vajaranant TS; Price MO; Price FW; Gao W; Wilensky JT; Edward DP Ophthalmology; 2009 Sep; 116(9):1644-50. PubMed ID: 19643499 [TBL] [Abstract][Full Text] [Related]
15. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients. Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424 [TBL] [Abstract][Full Text] [Related]
16. Predictors of long-term progression in the early manifest glaucoma trial. Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z; Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Prognosis of Pseudoexfoliation Glaucoma in Western India. Rao V; Doctor M; Rao G Asia Pac J Ophthalmol (Phila); 2015; 4(2):121-7. PubMed ID: 26065357 [TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for traumatic intraocular pressure elevation and traumatic glaucoma after open-globe injury. Bojikian KD; Stein AL; Slabaugh MA; Chen PP Eye (Lond); 2015 Dec; 29(12):1579-84. PubMed ID: 26381097 [TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma. Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]